CORPORATE EQUALITY INDEX 2O19 Rating Workplaces on Lesbian, Gay, Bisexual, Transgender, and Queer Equality
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Broken Bargain: Full Report
A BROKEN BARGAIN Discrimination, Fewer Bene!ts and More Taxes for LGBT Workers Full Report June 2013 National Center for TRANSGENDER EQUALITY With a foreword by Authors Partners This report was authored by: This report was developed in partnership with: 2 Movement Advancement Project Freedom to Work The Movement Advancement Project (MAP) is an Freedom to Work is a national organization dedicated independent think tank that provides rigorous research, to the notion that all Americans deserve the freedom insight and analysis that help speed equality for LGBT to build a successful career without fear of harassment people. MAP works collaboratively with LGBT organizations, or discrimination because of their sexual orientation advocates and funders, providing information, analysis and or gender identity. For more information, visit resources that help coordinate and strengthen their e!orts www.freedomtowork.org. for maximum impact. MAP also conducts policy research to inform the public and policymakers about the legal and National Partnership for Women & Families policy needs of LGBT people and their families. For more The National Partnership for Women & Families works to information, visit www.lgbtmap.org. promote fairness in the workplace, reproductive health and rights, access to quality a!ordable health care, Center for American Progress and policies that help women and men meet the dual The Center for American Progress (CAP) is a think tank demands of work and family. For more information, visit dedicated to improving the lives of Americans through www.nationalpartnership.org. ideas and action. CAP combines bold policy ideas with a modern communications platform to help shape the National Center for Transgender Equality national debate. -
AUTOMOTIVE AFTERMARKET OUTLOOK and REFLECTIONS from OUR Nd 42 ANNUAL SYMPOSIUM October 29 – October 30, 2018
GAMCO Investors, Inc. November 21, 2018 One Corporate Center Rye, NY 10580-1435 Tel (914) 921-5150 www.gabelli.com AUTOMOTIVE AFTERMARKET OUTLOOK AND REFLECTIONS FROM OUR nd 42 ANNUAL SYMPOSIUM October 29 – October 30, 2018 PRESENTING COMPANIES 10/31/2018 10/31/2017 11/1/2016 Company Exchange Ticker Price (a) Price (a) Price (a) AutoZone, Inc NYSE AZO $ 733.47 $ 589.50 $ 734.45 Boyd Group Income Fund (b) TSX BYD.UN 120.31 96.10 81.17 BYD Company Ltd (c) SHE 002594 46.79 62.79 55.57 Cooper Tire & Rubber Co. NYSE CTB 30.89 32.80 35.10 Dana, Inc. " DAN 15.47 30.49 15.00 Donaldson Company, Inc " DCI 51.28 47.21 35.46 Gentex Corporation NASDAQ GNTX 21.05 19.04 15.96 Genuine Parts Co. NYSE GPC 97.92 88.23 86.43 Lear Corporation " LEA 132.90 175.59 121.30 Monro, Inc. NASDAQ MNRO 74.40 49.35 53.32 Motorcar Parts of America, Inc " MPAA 21.18 28.91 26.19 Navistar International Corp NYSE NAV 33.49 42.31 23.01 O'Reilly Automotive, Inc NASDAQ ORLY 320.75 210.95 264.24 Penske Automotive Group NYSE PAG 44.02 46.62 42.83 Rush Enterprises, Inc. NASDAQ RUSHB 35.95 47.59 24.77 Standard Motor Products, Inc NYSE SMP 53.90 43.67 46.88 Superior Industries International, Inc. " SUP 9.83 15.55 22.95 Tenneco, Inc. " TEN 34.43 58.11 56.06 US Auto Parts Network, Inc. NASDAQ PRTS 1.19 2.56 2.27 Veoneer, Inc. -
Master Thesis Master's Programme in Industrial Management and Innovation, 120 Credits
Master Thesis Master's Programme in Industrial Management and Innovation, 120 credits Capturing Business Model Innovation Driven by the Emergence of New Technologies in Established Firms A Case Study at Siemens Healthineers Thesis in Industrial Innovation Management, 30 credits Halmstad 2018-06-16 Emma Bäckman, Josefin Ellmarker HALMSTAD UNIVERSITY Abstract Background: It is argued that the emergence of new technologies and the digitalization can improve the healthcare, make it more efficient, personalized and available for everyone. The healthcare has already begun to become more digitized and there is no doubt that this trend will continue. Moreover, it is argued that AI will have a major impact on the MedTech and healthcare industry. Problem discussion: To stay competitive it has been concluded that firms must update and rethink their business models constantly thus, to undertake business model innovation. This applies specially to established firms that have been successful with the same business model for a long time. Despite the fact that the existing literature addresses the importance of business model innovation, very little attention has been drawn to how to actually achieve this change. Purpose: The purpose of this study is to explore how business models in established firms within the MedTech industry develops over time due to the emergence of new technologies. More specifically, we focus on how artificial intelligence is influencing and will influence the business models in the MedTech industry. Methodology: This study has been performed through a single case study at Siemens Healthineers. The primary data has been gathered through four meetings with people with expertise in the field of artificial intelligence as well as the MedTech and healthcare industry. -
Sexual Orientation and Gender Identity Report on Good Practices
The Business Case for Diversity in the Workplace: sexual orientation and gender identity Report on good practices Contract n° JUST/2014/RDIS/PR/EQUA/0117 Written by: Lisa van Beek Alessandra Cancedda Carlien Scheele Date: 26 September 2016 Justice and Consumers EUROPEAN COMMISSION Directorate-General for Justice and Consumers Unit D3 – Non discrimination policies and Roma coordination European Commission B-1049 Brussels EUROPEAN COMMISSION The Business Case for Diversity in the Workplace: sexual orientation and gender identity Report on good practices Directorate-General for Justice and Consumers EU Consumer Programme 2016 Europe Direct is a service to help you find answers to your questions about the European Union. Freephone number (*): 00 800 6 7 8 9 10 11 (*) The information given is free, as are most calls (though some operators, phone boxes or hotels may charge you). LEGAL NOTICE This document has been prepared for the European Commission however it reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. More information on the European Union is available on the Internet (http://europa.eu). Luxembourg: Publications Office of the European Union, 2016 Numéro de projet: 2016.6410 Titre: The business case of diversity for enterprises, cities and regions with focus on sexual orientation and gender identity Version Numéro de Support/Volume ISBN DOI linguistique catalogue EN Paper/Volume_01 DS-04-16-814- 978-92-79- 10.2838/361589 PDF/Volume_01 EN-C 62186-4 10.2838/371 DS-04-16-814- 978-92-79- EN-N 62185-7 © European Union, 2016 Reproduction is authorised provided the source is acknowledged. -
1St Quarter Report
Quarterly Holdings Report for Fidelity® Variable Insurance Products: Mid Cap Portfolio March 31, 2021 VIPMID-QTLY-0521 1.799869.117 Schedule of Investments March 31, 2021 (Unaudited) Showing Percentage of Net Assets Common Stocks – 99.3% Shares Value Shares Value COMMUNICATION SERVICES – 3.5% Tapestry, Inc. 673,600 $ 27,759,056 Entertainment – 2.3% thredUP, Inc. (b) 26,600 620,578 Activision Blizzard, Inc. 1,187,600 $ 110,446,800 236,705,162 Cinemark Holdings, Inc. (a) 612,400 12,499,084 TOTAL CONSUMER DISCRETIONARY 1,215,512,530 Electronic Arts, Inc. 287,790 38,958,132 Live Nation Entertainment, Inc. (b) 245,500 20,781,575 182,685,591 CONSUMER STAPLES – 5.3% Interactive Media & Services – 0.5% Beverages – 0.6% Bumble, Inc. 39,400 2,457,772 C&C Group PLC (United Kingdom) (b) 7,982,445 30,922,922 IAC (b) 179,700 38,870,907 Monster Beverage Corp. (b) 183,000 16,669,470 41,328,679 47,592,392 Media – 0.7% Food & Staples Retailing – 2.6% Interpublic Group of Companies, Inc. 1,986,185 57,996,602 BJ’s Wholesale Club Holdings, Inc. (b) 1,891,100 84,834,746 Performance Food Group Co. (b) 1,118,796 64,453,838 TOTAL COMMUNICATION SERVICES 282,010,872 U.S. Foods Holding Corp. (b) 1,638,300 62,451,996 211,740,580 CONSUMER DISCRETIONARY – 15.0% Food Products – 1.1% Automobiles – 0.2% Nomad Foods Ltd. (b) 3,382,400 92,880,704 Harley‑Davidson, Inc. 474,400 19,023,440 Household Products – 1.0% Diversified Consumer Services – 0.6% Spectrum Brands Holdings, Inc. -
HD [email protected] Or by Writing to the Directors at the Following Address
THE HOME DEPOT PROXY STATEMENT AND NOTICE OF 2020 ANNUAL MEETING OF SHAREHOLDERS Thursday, May 21, 2020 at 9:00 a.m., Eastern Time COBB GALLERIA CENTRE, ATLANTA, GA Table of Contents INVESTOR FACTSHEET Strategy Our One Home Depot strategy aims to deliver shareholder value and grow our market share by providing best- in-class customer service through a seamless, interconnected shopping experience for our customers. We are continuously improving our online and in-store experience and providing enhanced training for our associates. In addition, to ensure we are the product authority in home improvement, we strive to provide unique and comprehensive product offerings, continued innovation, and exceptional convenience and value. To execute our strategy, we have committed approximately $11 billion over a multi-year period to investments in our stores, associates, interconnected and digital experience, pro customer experience, services business, supply chain, and product and innovation. Shareholder Return Principles Our first priority for our use of cash is investing in our business, as reflected by our One Home Depot strategy. Our use of the remainder of our cash is guided by our shareholder return principles: • Dividend Principle: Look to increase the dividend every year as we grow earnings • Return on Invested Capital Principle: Maintain a high return on invested capital, benchmarking all uses of excess liquidity against value created for shareholders through share repurchases • Share Repurchase Principle: After meeting the needs of the business, look to return excess cash to shareholders in the form of share repurchases Key Financial Performance Metrics Set forth below are key financial performance metrics for the indicated fiscal years. -
Medical Additive Manufacturing/ 3D Printing Annual Report 2018 Improving Public Health
Medical Additive Manufacturing/ 3D Printing Annual Report 2018 Improving Public Health Each year, healthcare needs and costs grow due to an aging population, the rise in chronic diseases, and more. In fact, global healthcare spending is projected to reach nearly $9 trillion by 20201. To address this, practitioners in the healthcare industry continue to look for innovations that can provide quality care to patients at a reasonable cost. But they can’t do it alone. Today, the manufacturing industry is an important partner, with one particularly bright opportunity focused on Medical Additive Manufacturing/3D Printing (AM3DP). From anatomical models to early bioprinting applications, the use of AM3DP is providing benefits for patients and physicians/institutions including: ■ Better patient outcomes ■ Less time in the operating room ■ Reduced costs In 2017, as outlined in this Annual Report, collaboration between hospitals, device manufacturers, U.S. Food and Drug Administration (FDA), and partners such as SME, led to extraordinary strides in identifying industry trends, opportunities, challenges and solutions. These partnerships drive efficiency through best practice sharing as well as accelerate innovation for applications such as bioprinting and tissue fabrication. They also lay the groundwork for 3D printing of organs and scaling up production of tissues which are still decades away. With millions of patients already directly impacted by the technology, this momentum continues into 2018 and beyond where AM3DP will continue to positively impact public health and drive strong business results. This 2017 Annual Report covers: COVER: Justin Ryan holds a pediatric heart model 3D-printed at the ■ Industry Overview Phoenix Children’s Hospital Cardiac 3D Print Lab. -
U.S. Corporate Scores 2018
01 DISCLOSURE INSIGHT ACTION U.S. CORPORATE SCORES 2018 02 CORPORATE DISCLOSURE TO INVESTORS IN NORTH AMERICA 124 9 28 510 63 192 CONTENTS 03 04 CDP scoring methodology 2018 06 The A-List: North America 08 Corporate scores 34 Appendix I: CDP Activity classification system (cdp-acs) 40 Appendix II: Investor Members and Signatories 46 Appendix III: CDP Supply Chain Members Important Notice The contents of this report may be used by anyone providing acknowledgment is given to CDP. This does not represent a license to repackage or resell any of the data reported to CDP or the contributing authors and presented in this report. If you intend to repackage or resell any of the contents of this report, you need to obtain express permission from CDP before doing so. CDP has prepared the data and analysis in this report based on responses to the CDP 2018 information request. No representation or warranty (express or implied) is given by CDP as to the accuracy or completeness of the information and opinions contained in this report. You should not act upon the information contained in this publication without obtaining specific professional advice. To the extent permitted by law, CDP does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this report or for any decision based on it. All information and views expressed herein by CDP are based on their judgment at the time of this report and are subject to change without notice due to economic, political, industry and firm-specific factors. -
2019 SEC Form 10-K (PDF File)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-14905 BERKSHIRE HATHAWAY INC. (Exact name of Registrant as specified in its charter) Delaware 47-0813844 State or other jurisdiction of (I.R.S. Employer incorporation or organization Identification No.) 3555 Farnam Street, Omaha, Nebraska 68131 (Address of principal executive office) (Zip Code) Registrant’s telephone number, including area code (402) 346-1400 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbols Name of each exchange on which registered Class A Common Stock BRK.A New York Stock Exchange Class B Common Stock BRK.B New York Stock Exchange 0.750% Senior Notes due 2023 BRK23 New York Stock Exchange 1.125% Senior Notes due 2027 BRK27 New York Stock Exchange 1.625% Senior Notes due 2035 BRK35 New York Stock Exchange 0.500% Senior Notes due 2020 BRK20 New York Stock Exchange 1.300% Senior Notes due 2024 BRK24 New York Stock Exchange 2.150% Senior Notes due 2028 BRK28 New York Stock Exchange 0.250% Senior Notes due 2021 BRK21 New York Stock Exchange 0.625% Senior Notes due 2023 BRK23A New York Stock Exchange 2.375% Senior Notes due 2039 BRK39 New York Stock Exchange 2.625% Senior Notes due 2059 BRK59 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: NONE Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. -
NASDAQ Stock Market
Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85 -
Team Captain Guide AIDS Run & Walk Chicago Saturday, October 2, 2010
Team Captain Guide AIDS Run & Walk Chicago Saturday, October 2, 2010 AIDS Run & Walk Chicago 2010 Saturday, October 2, 2010 Grant Park Team Captain Guide Table of Contents What is AIDS Run & Walk Chicago……………………………………. 3 Event Details ..………………………………………………………………….. 4 Preparing for Event Day …………………………………………………… 5 Team Building Tips …………………………………………………………… 6 Fundraising Tools ….…………………………………………………………. 7 Team Information Form …..………………………………………………. 8 Team Supplies Form ………………………………………………………… 9 Fundraising Form ……………………….……………………………………. 10 Online Fundraising Road Map ….……………………….…………….. 11 Participant Registration Form ………………………………………….. 12 Volunteer Information……………………………………………………… 13 Matching Gift Companies ………………………………………………… 14 2 About AIDS Run & Walk Chicago What is AIDS Run & Walk Chicago? AIDS Run & Walk Chicago is the largest AIDS-based outdoor fundraising event in the Midwest. Since its inception in 2001, AIDS Run & Walk Chicago has raised more than $3 million net to fight HIV/AIDS throughout the Chicagoland area. In 2009, more than 200 Teams joined forces to walk, run, and raise money in the fight against AIDS. With your help, we can surpass our goal of registering more than 300 Teams and raising $500,000 net! The AIDS Run & Walk Chicago Course takes place along the city’s lakefront, featuring Chicago’s famous skyline. Whether your teammates decide to run or walk along this spectacular course, all participants will be provided with the official AIDS Run & Walk Chicago T-Shirt, Race Bib, entertainment along the course, pre and post event activities, as well as lunch and treats! What Organizations Benefit from AIDS Run & Walk Chicago? AIDS Run & Walk Chicago benefits the AIDS Foundation of Chicago (AFC). AFC is the Midwest’s largest private source of philanthropic support for HIV/AIDS, a model of service coordination and Illinois’ principle advocate for people affected by HIV/AIDS. -
Drinking Water Compliance Plan
DRINKING WATER COMPLIANCE PLAN CHEMOURS FAYETTEVILLE WORKS RCRA PERMIT NO. NCD047368642-R2-M3 Prepared for: The Chemours Company FC, LLC Corporate Remediation Group 22828 NC Highway 87 W Fayetteville, NC 28306-7332 Prepared by: PARSONS 4701 Hedgemore Drive Charlotte, NC 28209 April 2019 Chemours PN 504552 Parsons PN 449338 DRINKING WATER COMPLIANCE PLAN TABLE OF CONTENTS TABLE OF CONTENTS 1.0 INTRODUCTION ................................................................................................... 1 1.1 Consent Order ................................................................................................... 1 1.2 Call Line ............................................................................................................. 1 2.0 PRIVATE WELL TESTING ................................................................................... 3 2.1 Additional Drinking Water Well Testing .......................................................... 3 2.2 Re-Analysis of Previously-Collected Groundwater Samples ......................... 4 2.3 Annual Re-Testing ............................................................................................ 5 2.4 Provision of Sampling Results ........................................................................ 5 2.5 Verification of Vacant Properties ..................................................................... 5 3.0 INTERIM REPLACEMENT OF PRIVATE DRINKING WATER SUPPLIES .......... 6 3.1 Replacement Drinking Water Supplies ...........................................................